Key In-vitro Diagnostics for Cardiology and Neurology Market Players:
- Roche Holding AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- Siemens Healthineers AG
- Danaher Corp. (Beckman Coulter)
- Thermo Fisher Scientific
- QuidelOrtho Corporation
- Sysmex Corporation
- bioMérieux SA
- Diasorin S.p.A.
- Werfen
- Fujirebio
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- Johnson & Johnson
- Quest Diagnostics
- Labcorp
- Randox Laboratories Ltd.
- Mindray Bio-Medical
- PerkinElmer, Inc.
- Agilent Technologies, Inc.
The global IVD market, particularly in the areas of cardiology and neurology, is highly competitive. Companies such as Roche, Abbott, and Thermo Fisher are highly competitive based on innovations in diagnostics. Forces of innovation, such as Beckman Coulter's recent partnership with Fujirebio to facilitate the development of their assays to detect and diagnose neurodegenerative diseases, represent innovations that are securing future progress in this sector.
Below is the list of some prominent players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of the in-vitro diagnostics for cardiology and neurology market was over USD 19.8 billion.
The market size for the in-vitro diagnostics for cardiology and neurology market is projected to reach USD 43.3 billion by the end of 2035, expanding at a CAGR of 9.1% during the forecast period, i.e., 2026-2035.
The major players in the market are Roche Holding AG, Abbott Laboratories, Siemens Healthineers AG, Danaher Corp. (Beckman Coulter), Thermo Fisher Scientific, QuidelOrtho Corporation, and others.
In terms of product & service, the reagents & kits segment is anticipated to garner the largest market share of 55.4% by 2035 and display lucrative growth opportunities during 2026-2035.
The market in North America is projected to hold the largest market share of 45.2% by the end of 2035 and provide more business opportunities in the future.
